When to consider an implantable cardioverter defibrillator following myocardial infarction?

Heart. 2015 Dec;101(24):1996-2000. doi: 10.1136/heartjnl-2015-307788. Epub 2015 Nov 2.

Abstract

After reading this article the reader should be familiar with: Current guidelines for implantable cardioverter defibrillator (ICD) use post myocardial infarction (MI) and ischaemic cardiomyopathy. Primary prevention ICD guidelines. Secondary prevention ICD guidelines. Non-sustained ventricular tachycardia in patients post MI and the use of ICDs. Programming ICDs.

Publication types

  • Review

MeSH terms

  • Arrhythmias, Cardiac / diagnosis
  • Arrhythmias, Cardiac / etiology
  • Arrhythmias, Cardiac / mortality
  • Arrhythmias, Cardiac / physiopathology
  • Arrhythmias, Cardiac / prevention & control*
  • Defibrillators, Implantable*
  • Electric Countershock / adverse effects
  • Electric Countershock / instrumentation*
  • Electric Countershock / mortality
  • Humans
  • Myocardial Infarction / complications
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / mortality
  • Myocardial Infarction / physiopathology
  • Myocardial Infarction / therapy*
  • Patient Selection
  • Primary Prevention / instrumentation*
  • Prosthesis Design
  • Recurrence
  • Risk Assessment
  • Risk Factors
  • Secondary Prevention / instrumentation*
  • Stroke Volume
  • Time Factors
  • Time-to-Treatment
  • Treatment Outcome
  • Ventricular Function, Left